Cited by 43Alzheimer's disease research and treatmentsDementia and Cognitive Impairment ResearchNeuroinflammation and Neurodegeneration Mechanisms

Impairment of mitogenic activation of peripheral blood lymphocytes in Alzheimer's disease

Stieler, Jens T., Lederer, Carla, Brückner, Martina K., Wolf, Henrike, Holzer, Max, Gertz, Hermann-Josef, Arendt, Thomas·2001·Neuroreport

Abstract

Cell-cycle dysregulation might be critically involved in the process of neurodegeneration in Alzheimer's disease (AD). We now provide evidence for a dysfunction of the cell division cycle as a more general cellular phenomenon of the disease. Peripheral blood lymphocytes, stimulated with mitogenic compounds, were less able to express CD69, an early proliferation marker, in AD patients than in age-matched controls. Expression levels of CD69 of both T-cells and B-cells correlated inversely with the Mini-mental Scale. The results suggest that a systemic failure of cellular proliferation control might be of critical importance for the pathomechanism of AD.

Integrity signals

Registry

Crossref · 10.1097/00001756-200112210-00023

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Stieler, J. T., Lederer, C., Brückner, M. K., Wolf, H., Holzer, M., Gertz, H.-J., & Arendt, T.
Affiliations
Leipzig University (DE)
Venue
Neuroreport
Published
2001-12
Volume
12
Issue
18
Pages
3969-3972
ISSN
0959-4965 (ISSN-L)
OpenAlex
W1975330896
Cited by
43
References
1
Citations by year
2026: 1 · 2021: 2 · 2019: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 6 · 2014: 1 · 2013: 2 · 2012: 3
FWCI
1.14
Type
journal article
Language
en
Open access
closed
Locations
  • Neuroreport (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
Alzheimer's disease, peripheral blood lymphocytes, mitogen stimulation, CD69, cell proliferation, cell cycle dysregulation, T cells, B cells, Mini-Mental State Examination, neurodegeneration, immunosenescence
MeSH terms
CD69 Antigens, Aged, Aged, 80 and over, Alzheimer Disease, Antigens, Differentiation, T-Lymphocyte, Apolipoproteins E, B-Lymphocytes, Cell Division, Flow Cytometry, Genotype, Humans, Mitogens, T-Lymphocytes, Antigens, CD, Lectins, C-Type

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review